G8971 – Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given
HCPCS Level II code · G codes: Procedures / Professional Services (Temporary)
HCPCS codeG8971
- Long description
- Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given
- Short description
- Warfrn or othr antcog no rx
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
M5BSpecialist - psychiatry- Added
- January 1, 2013
- Last change
- January 1, 2018 – No change
- Termination date
- December 31, 2017
Frequently asked questions
What is HCPCS code G8971?
G8971 is a HCPCS Level II code for warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given. It was discontinued on December 31, 2017.
Does Medicare cover G8971?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby G codes
- G8963 – Cardiac stress imaging performed primarily for monitoring of asymptomatic patient who had pci within 2 years
- G8964 – Cardiac stress imaging test performed primarily for any other reason than monitoring of asymptomatic patient who had pci within 2 years (e.g., symptomatic patient, patient greater than 2 years since pci, initial evaluation, etc)
- G8965 – Cardiac stress imaging test primarily performed on low chd risk patient for initial detection and risk assessment
- G8966 – Cardiac stress imaging test performed on symptomatic or higher than low chd risk patient or for any reason other than initial detection and risk assessment
- G8967 – Fda approved oral anticoagulant is prescribed
- G8968 – Documentation of medical reason(s) for not prescribing an fda-approved anticoagulant (e.g., present or planned atrial appendage occlusion or ligation or patient being currently enrolled in a clinical trial related to af/atrial flutter treatment)
- G8969 – Documentation of patient reason(s) for not prescribing an oral anticoagulant that is fda approved for the prevention of thromboembolism (e.g., patient preference for not receiving anticoagulation)
- G8970 – No risk factors or one moderate risk factor for thromboembolism
- G8972 – One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboembolism
- G8973 – Most recent hemoglobin (hgb) level < 10 g/dl
- G8974 – Hemoglobin level measurement not documented, reason not given
- G8975 – Documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e.g., patients who have non-renal etiologies of anemia [e.g., sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to chemotherapy for diagnosis of malignancy, postoperative bleeding, active bloodstream or peritoneal infection], other medical reasons)
- G8976 – Most recent hemoglobin (hgb) level >= 10 g/dl
- G8977 – I intend to report the oncology measures group
- G8978 – Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals
- G8979 – Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.